1. Review mechanisms of cardiotoxicity associated with pharmacologic therapies in patients with malignancies.

2. Describe measures that can be used to prevent and monitor treatment-related toxicities.

Session date: 
06/28/2018 - 8:00am to 9:00am CDT
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Hannah DeLuna, PharmD